ZYSANTE Trademark

Trademark Overview

On Tuesday, May 14, 2013, a trademark application was filed for ZYSANTE with the United States Patent and Trademark Office. The USPTO has given the ZYSANTE trademark a serial number of 79132469. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Saturday, May 13, 2023. This trademark is owned by Boehringer Ingelheim International GmbH. The ZYSANTE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
zysante

General Information

Serial Number79132469
Word MarkZYSANTE
Filing DateTuesday, May 14, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateSaturday, May 13, 2023
Registration Number4486830
Registration DateTuesday, February 25, 2014
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; and pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 26, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
Address55218 Ingelheim
DE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDE

Trademark Events

Event DateEvent Description
Sunday, December 10, 2023NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, December 10, 2023DEATH OF INTERNATIONAL REGISTRATION
Sunday, March 13, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Monday, February 14, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Monday, February 14, 2022INVALIDATION PROCESSED
Tuesday, October 26, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 26, 2021CANCELLED SECTION 71
Thursday, July 24, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, July 8, 2014FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, July 8, 2014FINAL DISPOSITION PROCESSED
Sunday, May 25, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 25, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, December 10, 2013NOTIFICATION PROCESSED BY IB
Tuesday, December 10, 2013PUBLISHED FOR OPPOSITION
Wednesday, November 20, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 20, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, November 20, 2013NOTICE OF PUBLICATION
Friday, November 1, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 28, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, October 7, 2013AMENDMENT FROM APPLICANT ENTERED
Monday, October 7, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 4, 2013ASSIGNED TO LIE
Thursday, October 3, 2013PAPER RECEIVED
Monday, September 23, 2013REFUSAL PROCESSED BY IB
Monday, September 16, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 5, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, September 5, 2013REFUSAL PROCESSED BY MPU
Thursday, September 5, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 4, 2013NON-FINAL ACTION WRITTEN
Friday, August 30, 2013ASSIGNED TO EXAMINER
Wednesday, July 17, 2013APPLICATION FILING RECEIPT MAILED
Saturday, July 13, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 12, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, July 11, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

zysante system pharmaceutical preparations diseases disorders treatment blood nervous peripheral genitourinary